Company / Income Tax
CRISPR Therapeutics AG Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$3.6M
FY2025
5-year range
-$325.0K / $3.6M
FY2021-FY2025
Trend
+1.3%
vs FY2024
Sector context
#53 of 202
Health Care
What the data says
At $4M, CRISPR Therapeutics AG's income tax ranks #150 of 202 in the Health Care sector. Income Tax has increased for 3 consecutive years, from -$325,000 in FY2022 to $4M in FY2025.
Based on SEC 10-K filings.
$4M in FY2025 with a 5-year CAGR of +35.0%.
Increased from $3M to $4M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +35.0%
- 10-Year CAGR
- -
Sector benchmark
#150 of 202 in Health CareTop 74% of 202This company $3.6M Sector average $119.7M
▼
-97.0% below sector average
Key checks
Key Insights
- CRISPR Therapeutics AG's income tax has grown for 3 consecutive years.
- 5-year CAGR of +35.0%, indicating consistent growth.
- In FY2025, income tax increased 1.3% year-over-year.
- Ranks #53 out of 202 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.6M | +1.3% |
| FY2024 | $3.6M | +24.2% |
| FY2023 | $2.9M | +988.6% |
| FY2022 | -$325.0K | -117.4% |
| FY2021 | $1.9M | +131.1% |
| FY2020 | $809.0K | +80.6% |
| FY2019 | $448.0K | -19.0% |
| FY2018 | $553.0K | -68.4% |
| FY2017 | $1.7M | +261.4% |
| FY2016 | $484.0K | +6814.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026